XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 186,874 $ 145,054
Marketable securities 125,939 152,167
Total cash, cash equivalents, and marketable securities 312,813 297,221
Accounts receivable 163,915 255,150
Unbilled receivables 182,257 213,719
Other current assets 78,526 80,388
Total current assets 737,511 846,478
Unbilled receivables 70,486 95,806
Goodwill 81,593 81,399
Other long-term assets 302,848 333,989
Total assets 1,192,438 1,357,672
Current liabilities:    
Accounts payable 8,438 18,195
Accrued expenses 53,110 50,355
Accrued compensation and related expenses 70,965 127,728
Deferred revenue 311,330 325,212
Other current liabilities 17,269 17,450
Total current liabilities 461,112 538,940
Convertible senior notes, net 498,140 593,609
Operating lease liabilities 72,886 79,152
Other long-term liabilities 14,904 15,128
Total liabilities 1,047,042 1,226,829
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 83,212 and 82,436 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 832 824
Additional paid-in capital 310,016 229,602
Accumulated deficit (144,091) (76,513)
Accumulated other comprehensive (loss) (21,361) (23,070)
Total stockholders’ equity 145,396 130,843
Total liabilities and stockholders’ equity $ 1,192,438 $ 1,357,672